Skip to main content
SpringerLink
Log in

Annotation: Oral deferiprone — controversies on its efficacy and safety

  • Symposium: Hematology/Oncology-II
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Choudhry VP, Desai N, Pati HP and Nanu A. Current management of hemozygous beta thalassemia.Ind Pediatr 1991; 28: 1221–1229.

    CAS  Google Scholar 

  2. Andersoo WF, Hiller MC (eds).Development of Iron Chelators for Clinical Use. National Institute of Health. Bethesda, U.S.A. 1975; 1–277.

    Google Scholar 

  3. Martell AE, Anderson WF, Badman DG (eds).Development of Iron Chelators for Clinical Use. Amsterdam: Elsevier Scientific Publishers, 1980; 1–311.

    Google Scholar 

  4. Oral chelation in the treatment of thalassemia and other diseases.Drugs Today 1992; 28 (suppl A) : 1–187.

  5. Goudsmit R, Kersten MJ. Long term treatment of transfusion hemosiderosis with the oral iron chelator L1.Drugs Today 1992; 28 (suppl 1): 133–135.

    Google Scholar 

  6. Dersten MJ, Lange RV, Smeets MEPet al. Long term treatment of transfusional iron overload with oral iron chelator 1–2 dimethyl, 3 hydroxypyrid 4-one (Deferiprone).International Congress on oral chelation in the treatment of thalassemia and other diseases. 1995; p 16.

  7. Agarwal MB, Gupta SS, Viswanathan Cet al. Long term assessment of efficacy and safety of L1, an oral iron chelator in transfusion dependent thalassemia: Indian trial.Br J Haematol 1992; 82 : 460–466.

    PubMed  CAS  Google Scholar 

  8. Choudhry VP and Pati HP. Oral iron chelator deferiprone. In : Suraj Gupta (ed).Recent Advances in Pediatrics. Jaypee Brothers 1996; Vol 6 : pp 229–240.

  9. Choudhry VP, Malviya AN, Pati HP, Saxena A and Subramaniyam V. To evalaute the efficacy and safety of oral iron chelator 1–2 Demethyl 3 Hydroxypyrid-4-one chelator (L1) compound in mutiple transfused thalassemic patients (Report submitted to Cipla) 1995.

  10. Mazza P, Amurri B, Lazzari Get al. Oral iron chelating therapy. A single centre interim report on deferiprone (L) in thalassemia.Hematologica 1998; 83: 496–501.

    CAS  Google Scholar 

  11. Olivieri NF, Brittenham GM, Matsui Det al. Iron chelation therapy with oral deferiprone in patients with thalassemia major.N Engl J Med 1995; 332: 918–22.

    Article  PubMed  CAS  Google Scholar 

  12. Olivieri NF. Randomized trial of deferiprone (L1) and deferoxamine (DFO) in thalassemia major.Blood 1996; 88: 651a abstract.

    Google Scholar 

  13. Hoffbrand AV, Al Refaie F, Davis Bet al. Long term trial of deferiprone in 51 transfusion dependent iron overloaded patients.Blood 1998; 91: 295–300.

    PubMed  CAS  Google Scholar 

  14. Olivieri NF, Brittenham GM, McLaren CEet al. Long term safety and effectiveness of iron chelation therapy with deferiprone for thalassemia major.N Engl J Med 1998; 339: 417–23.

    Article  PubMed  CAS  Google Scholar 

  15. Agarwal MB, Gupta SS, Vishwanathan Cet al. Long term efficacy and toxicity of L1 oral iron chelation in transfusion dependent thalassemics over the last three years (1989–92) (Abstract) 5thInternational Conference on Thalassemia and Haemoglobinopathies held at Cyprus 1993; p 192.

  16. Hoffbrand AV. Oral iron chelation.Seminar Hematol 1996; 33: 1–8.

    CAS  Google Scholar 

  17. Citrin OD and Koren D. Oral iron chelation with deferiprone.Fed Clin N Am 1997; 44: 235–247.

    Google Scholar 

  18. Pati HP and Choudhry VP. Deferiprone (L) associated neutropenia in beta thalassemia major. An Indian experience.Eurp J Hematol (Submitted for publication).

Download references

Author information

Author notes

  1. V. P. Choudhry

    Present address: Department of Hematology, All India Institute of Medical Sciences, 110 029, New Delhi

Authors and Affiliations

    Authors
    1. V. P. Choudhry
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Choudhry, V.P. Annotation: Oral deferiprone — controversies on its efficacy and safety. Indian J Pediatr 65, 825–828 (1998). https://doi.org/10.1007/BF02831341

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF02831341

    Keywords

    Search

    Navigation